Contact Us

HOTEL NEWS

Global Biopharma Thought Leaders Gather in London: Join the 2024 GenScript Biotech Global Forum for Cutting-Edge Insights

Oct 25, 2024

PISCATAWAY,N.J.,Oct. 24,2024-- Cell therapy,gene therapy,andmRNA vaccines are revolutionizing healthcare,offering innovative treatments for a wide range of diseases. However,as these therapies progres

EpiVax and CUBRC Awarded FDA Contract Worth $2M for Development of Control Peptides for Immunogenicity Risk Assessment Assays Supporting Regulatory Filings of Generic Peptide Drugs

Oct 25, 2024

PROVIDENCE,R.I.,Oct. 24,2024--EpiVax,Inc. ("EpiVax") and CUBRC,Inc. ("CUBRC") announce today that they have been awarded a two-year,$2 million contract (#75F40124C00094) from the

Farmmi, Inc. Enters into Strategic Cooperation Agreement Aimed to Further Expand Its Logistic Services Business

Oct 25, 2024

LISHUI,China,Oct. 24,2024-- Farmmi,Inc. ("Farmmi" or the "Company") (NASDAQ: FAMI),an agriculture products supplier in China,today announced that the Company\'s subsidiary,FARMMI U

Massimo Demonstrates Innovation and Growth Potential at the 2024 Equip Expo in Louisville, KY

Oct 25, 2024

Strong Interest in Motor Sports Vehicles at Expo Highlights Strategic Business Expansion and Growth Opportunities in 2025

CLPS Incorporation Declares Special Cash Dividend of $0.13 Per Share for Third Consecutive Fiscal Years

Oct 25, 2024

HONG KONG,Oct. 24,2024-- CLPS Incorporation (the "Company" or "CLPS") (Nasdaq: CLPS),today announced that its Board of Directors has declared a special cash dividend of $0.13 per s

Nature's Miracle Holding Inc. Launches Wholly Owned Subsidiary, NM Rebate Inc. to Complement Core LED Lighting Segment

Oct 25, 2024

~ Launch of Rebate Division is Expected to Boost Sales and Margins as Program will Offset the Cost of LED Product Installation ~

1 ... 131 132 133 134 135 136 137 ... 240